Evolving Role of the Neurologist in the Diagnosis and Treatment of Chronic Noncancer Pain
- Cancer patients urged to inform MDs of pain. // CMAJ: Canadian Medical Association Journal;07/01/97, Vol. 157 Issue 1, p9
Reports on a poster campaign launched by the Canadian Cancer Society and Canadian Palliative Care Association. Goal to encourage cancer patients to talk to physicians about pain management; Comments from Dr. Neil Hagen.
- Benchmarking review of locally devised cancer pain guidelines. Finlay, I; Bowdler, J; Tebbit, P // Palliative Medicine;May2000, Vol. 14 Issue 3, p231
Presents results of the Clinical Issues Committee of the British National Council for Hospice & Palliative Care Services' review of cancer pain guidelines to asses recommended practices across England, Wales and Northern Ireland. Variation in content, quality, ease of use and layout of the...
- A survey of the use of alternative strong opioids. Lee, B; Cole, C; Gwilliam, B; Broadley, K; Hardy, J // Palliative Medicine;May2000, Vol. 14 Issue 3, p238
Investigates the use of alternative strong opioids for cancer pain. Reasons for changing morphine to another opioid; Outcomes in terms of resolution of the opioid-induced adverse effects; Dosage and administration routes; Common opioid changes.
- Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study. Zeppetella, G. // Palliative Medicine;Jul2001, Vol. 15 Issue 4, p323
The effects of sublingual fentanyl citrate (SLFC) were assessed in 11 hospice inpatients with cancer-related breakthrough pain. Patients were asked to rate their pain, using a visual analogue scale, before SLFC, then after 3, 5, 10, 15, 30, 45 and 60 min. Six patients (55%) had reductions in...
- Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Radbruch, L.; Sabatowski, R.; Petzke, F.; Brunsch-Radbruch, A.; Grond, S.; Lehmann, K.A. // Palliative Medicine;Jul2001, Vol. 15 Issue 4, p309
Transdermal fentanyl was released in Germany in 1995. From October 1996 to February 1998 transdermal treatment was documented for 1005 patients (506 men and 499 women with a mean age of 60 years, range 20-92 years) with chronic pain in an open survey including 290 physicians from hospitals and...
- Pharmacologic management of pain in patients with cancer. Andolsek, Kathryn M. // American Family Physician;2/15/1997, Vol. 55 Issue 3, p922
Reports that it was revealed by a study in a 1996 publication of `The New England Journal of Medicine,' by M.H. Levy, that holistic management of patients with cancer requires a solid foundation in the principles of pain management. `Pharmacologic treatment of cancer pain,' original title of...
- Eliminating pain, the unnecessary baggage of cancer. // Executive Health's Good Health Report;May94, Vol. 30 Issue 8, p1
Reports on guidelines for treatment of cancer pain. Prevalence and consequences of cancer pain; Formation of a panel by the Department of Health and Human Services to study cancer pain; Pain management principles and procedures; Pain evaluation; Principles of drug therapy; Importance of active...
- Management of cancer pain: Adults. // American Family Physician;6/1/94, Vol. 49 Issue 8, p1853
Offers suggestions for the management of cancer pain in adults. Importance of flexibility; Use of team approach involving patients, their families and health care providers; Barriers to cancer pain management; Recommended clinical approach; Pain assessment; Pharmacologic treatment options.
- Multicentre study of cancer pain and its treatment in France. Larue, Francois; Colleau, Sophie M. // BMJ: British Medical Journal (International Edition);4/22/95, Vol. 310 Issue 6986, p1034
Describes the treatment of cancer pain in France. Evaluation of the predictive factors for inadequate management; Undertreatment of cancer pain in France; Need for changes in patient care.